The USFDA has issued 8 observations for the drug product facility and API facility at Mandideep. The US drug regulator has inspected company’s Mandideep unit-1 facility during November 14-23, 2022.
Dow ends 400 points higher as investors buy AI stocks; Microsoft rallies
Wall Street experienced gains on Friday, driven by positive performance from Microsoft and AI-related technology stocks. High oil prices and rising US Treasury yields created